Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients?

Update Item Information
Title Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients?
Creator Sui H. Wong, MRCP; Gordon T. Plant, FRCP, FRCOphth; Wayne Cornblath, MD
Affiliation Department of Neuro-ophthalmology (SHW, GTP), Moorfields Eye Hospital, London, United Kingdom; Medical Eye Unit (SHW, GTP), St. Thomas' Hospital, London, United Kingdom; Department of Neuro-ophthalmology (SHW, GTP), National Hospital for Neurology and Neurosurgery, London, United Kingdom; and Departments of Neurology and Ophthalmology (WC), University of Michigan, Ann Arbor, Michigan
Subject Humans; Immunosuppressive Agents; Myasthenia Gravis; Secondary Prevention
OCR Text Show
Date 2016-03
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s6dc1wbn
Setname ehsl_novel_jno
ID 1276465
Reference URL https://collections.lib.utah.edu/ark:/87278/s6dc1wbn
Back to Search Results